Sean Carrick - Net Worth and Insider Trading

Sean Carrick Net Worth

The estimated net worth of Sean Carrick is at least $119,765 dollars as of 2024-05-25. Sean Carrick is the Principal Executive Officer of Nascent Biotech Inc and owns about 1,227,601 shares of Nascent Biotech Inc (NBIO) stock worth over $119,765. Details can be seen in Sean Carrick's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sean Carrick has not made any transactions after 2015-10-08 and currently still holds the listed stock(s).

Transaction Summary of Sean Carrick

To

Sean Carrick Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sean Carrick owns 1 companies in total, including Nascent Biotech Inc (NBIO) .

Click here to see the complete history of Sean Carrick’s form 4 insider trades.

Insider Ownership Summary of Sean Carrick

Ticker Comapny Transaction Date Type of Owner
NBIO Nascent Biotech Inc 2015-10-08 director & President

Sean Carrick Latest Holdings Summary

Sean Carrick currently owns a total of 1 stock. Sean Carrick owns 1,227,601 shares of Nascent Biotech Inc (NBIO) as of October 8, 2015, with a value of $119,765.

Latest Holdings of Sean Carrick

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBIO Nascent Biotech Inc 2015-10-08 1,227,601 0.10 119,765

Holding Weightings of Sean Carrick


Sean Carrick Form 4 Trading Tracker

According to the SEC Form 4 filings, Sean Carrick has made a total of 0 transactions in Nascent Biotech Inc (NBIO) over the past 5 years. The most-recent trade in Nascent Biotech Inc is the acquisition of 1,030,401 shares on October 8, 2015, which cost Sean Carrick around $1 Million.

Insider Trading History of Sean Carrick

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sean Carrick Trading Performance

GuruFocus tracks the stock performance after each of Sean Carrick's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sean Carrick is -15%. GuruFocus also compares Sean Carrick's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sean Carrick within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sean Carrick's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sean Carrick

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 45
Relative Return to S&P 500(%) 40.74

Sean Carrick Ownership Network

Ownership Network List of Sean Carrick

No Data

Ownership Network Relation of Sean Carrick


Sean Carrick Owned Company Details

What does Nascent Biotech Inc do?

Who are the key executives at Nascent Biotech Inc?

Sean Carrick is the director & President of Nascent Biotech Inc. Other key executives at Nascent Biotech Inc include director & CFO Lowell Thomas Holden , director & Senior VP Business Development Brandon Price , and director & CEO Mark Glassy .

Nascent Biotech Inc (NBIO) Insider Trades Summary

Over the past 18 months, Sean Carrick made no insider transaction in Nascent Biotech Inc (NBIO). Other recent insider transactions involving Nascent Biotech Inc (NBIO) include a net purchase of 130,000 shares made by Lowell Thomas Holden ,

In summary, during the past 3 months, insiders sold 0 shares of Nascent Biotech Inc (NBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nascent Biotech Inc (NBIO) were sold and 130,000 shares were bought by its insiders, resulting in a net purchase of 130,000 shares.

Nascent Biotech Inc (NBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nascent Biotech Inc Insider Transactions

No Available Data

Sean Carrick Mailing Address

Above is the net worth, insider trading, and ownership report for Sean Carrick. You might contact Sean Carrick via mailing address: 631 Us Hwy 1, Suite 407, North Palm Beach Fl 33408.

Discussions on Sean Carrick

No discussions yet.